|Project Title||TreeScan for Drugs|
Monday, June 26, 2017
This workgroup will assess the feasibility of using the tree-based scan statistic routinely in a drug setting. An appropriate exposure (i.e. short-term, fixed-length) will be selected to test the use with self-controlled tree-temporal scan statistic.
Judy Maro PhD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
Elande Baro PhD, MS; Rima Izem PhD; Michael Nguyen MD; Jacqueline Puigbo PhD, MS; Esther Zhou MD, PhD; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
David Cole BM; Meighan Rogers Driscoll MPH; Austin Cosgrove BS; Inna Dashevsky MS; Megan Reidy MPH; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
Joshua J. Gagne PharmD, ScD; Martin Kulldorff PhD; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA